Acadia Healthcare Company, Inc.
Income Statement
| Line Item | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $828.8M | $821.5M | $851.6M | $869.2M | $770.5M | $774.2M | $815.6M | $796.0M |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — | — | — |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $11.0M | $-1.17B | $40.0M | $50.0M | $13.5M | $38.0M | $98.6M | $106.5M |
| Operating Margin | 1.3% | -142.4% | 4.7% | 5.8% | 1.7% | 4.9% | 12.1% | 13.4% |
| Interest Expense | — | — | — | — | — | — | — | — |
| Pretax Income | $11.0M | $-1.17B | $40.0M | $50.0M | $13.5M | $38.0M | $98.6M | $106.5M |
| Income Tax Expense | $6.5M | $7.8M | $1.7M | $12.1M | $4.4M | $4.5M | $27.2M | $25.6M |
| Net Income | $4.1M | $-1.18B | $36.2M | $30.1M | $8.4M | $32.6M | $68.1M | $78.5M |
| Net Margin | 0.5% | -143.3% | 4.3% | 3.5% | 1.1% | 4.2% | 8.4% | 9.9% |
| EPS (Basic) | $0.05 | $-12.98 | $0.40 | $0.33 | $0.09 | $0.35 | $0.74 | $0.86 |
| EPS (Diluted) | $0.05 | $-12.98 | $0.40 | $0.33 | $0.09 | $0.36 | $0.74 | $0.85 |
| Shares Outstanding (Basic) | 90.5M | 90.7M | 90.4M | 90.3M | 91.7M | 91.6M | 91.7M | 91.6M |
| Shares Outstanding (Diluted) | 90.9M | 90.7M | 90.6M | 90.4M | 92.0M | 92.1M | 92.2M | 92.0M |
| Dividends Per Share | — | — | — | — | — | — | — | — |